等待开盘 09-09 09:30:00 美东时间
-0.300
-3.01%
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
Truist Securities analyst Mark Hughes maintains Goldman Sachs BDC (NYSE:GSBD) with a Hold and raises the price target from $9 to $10.
08-11 01:51
Goldman Sachs BDC (NYSE:GSBD) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.31 by 19.35 percent. This is a 2.63 percent decrease over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $83.724 million w...
08-07 05:49
今日重点评级关注:HC Wainwright & Co.:维持Rockwell Medical"买入"评级,目标价从2美元升至20美元;Canaccord Genuity:维持创力"买入"评级,目标价从10.5美元升至11美元
07-10 17:36
B of A Securities analyst Derek Hewett downgrades Goldman Sachs BDC (NYSE:GSBD) from Neutral to Underperform and lowers the price target from $9 to $8.5.
07-09 19:33
The Print Goldman Sachs BDC (NYSE:GSBD) held its base dividend flat at $0.32 th...
06-01 20:50
Smart credit team Ares Mgmt bought discounted BDCs aggressively in Q1 2026. They're not guessing but expressing conviction in 17 positions.
05-25 01:33
今日重点评级关注:TD Cowen:维持Strategy"买入"评级,目标价从395美元升至400美元;摩根士丹利:维持Cipher Digital"超配"评级,目标价从40.5美元升至42.5美元
05-20 11:55
Truist Securities analyst Mark Hughes maintains Goldman Sachs BDC (NYSE:GSBD) with a Hold and lowers the price target from $10 to $9.
05-20 01:34
Goldman Sachs BDC (NYSE:GSBD) reported quarterly earnings of $0.22 per share which missed the analyst consensus estimate of $0.29 by 24.14 percent. This is a 46.34 percent decrease over earnings of $0.41 per share from
05-08 17:35